To investigate whether epinephrine and USP10 inhibited PLAGL2 protein degradation, we treated HCC cells with the protein synthesis inhibitor cycloheximide (CHX) (Fig. 6e, f, and Supplementary Fig. 7c, d). Here, USP10 is linked to hepatocellular carcinoma.